0000950103-21-008458.txt : 20210604 0000950103-21-008458.hdr.sgml : 20210604 20210604185212 ACCESSION NUMBER: 0000950103-21-008458 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210602 FILED AS OF DATE: 20210604 DATE AS OF CHANGE: 20210604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Urist Marshall CENTRAL INDEX KEY: 0001838139 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39329 FILM NUMBER: 21997813 MAIL ADDRESS: STREET 1: C/O ROYALTY PHARMA PLC STREET 2: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Royalty Pharma plc CENTRAL INDEX KEY: 0001802768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 883-0200 MAIL ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 4 1 dp152317_4-urist.xml FORM 4 X0306 4 2021-06-02 0 0001802768 Royalty Pharma plc RPRX 0001838139 Urist Marshall C/O ROYALTY PHARMA PLC 110 EAST 59TH STREET NEW YORK NY 10022 0 1 0 0 EVP & Co-Head Research & Inv. Class A Ordinary Shares 2021-06-02 4 S 0 14566 41.5248 D 33134 D Class A Ordinary Shares 19020 I By IRA The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.18 to $41.86 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. All reported transactions were effected pursuant to a 10b5-1 plan adopted by the reporting person on March 29, 2021. /s/ Jason Mehar, as Attorney-in-Fact for Marshall Urist 2021-06-04